BA
NVO

Bridgewater Advisors’s Novo Nordisk NVO Stock Holding History

Bridgewater Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$518K Sell
11,007
-749
-6% -$35.5K 0.03% 240
2025
Q4 		$697K Buy
11,756
+160
+1% +$8.18K 0.05% 195
2025
Q3 		$539K Sell
11,596
-964
-8% -$56.4K 0.04% 237
2025
Q2 		$677K Buy
12,560
+615
+5% +$41.8K 0.05% 190
2025
Q1 		$778K Sell
11,945
-447
-4% -$36.9K 0.07% 148
2024
Q4 		$1.01M Sell
12,392
-94
-0.8% -$10.2K 0.11% 87
2024
Q3 		$1.4M Sell
12,486
-20
-0.2% -$2.67K 0.15% 78
2024
Q2 		$1.6M Buy
+12,506
New +$1.66M 0.2% 68
2014
Q2 		$268K Buy
11,618
+16
+0.1% +$353 0.22% 74
2014
Q1 		$265K Buy
11,602
+402
+4% +$8.56K 0.27% 66
2013
Q4 		$207K Buy
+11,200
New +$195K 0.21% 74

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Bridgewater Advisors's NVO Position: Q1 2026 in Review

Bridgewater Advisors reduced its Novo Nordisk (NVO) stake by 6.4% in Q1 2026, selling an estimated $35.5K and leaving 11,007 shares worth $518K. The position accounts for 0.03% of the portfolio, ranked #240.

Bridgewater Advisors first reported a position in NVO in Q4 2013 and has held it in 11 quarters since. The position peaked at $1.6M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Bridgewater Advisors held 11,007 shares of Novo Nordisk worth $518K as of Q1 2026.
  • Bridgewater Advisors sold 749 Novo Nordisk shares in Q1 2026, an estimated $35.5K.
  • Novo Nordisk made up 0.03% of Bridgewater Advisors's portfolio in Q1 2026, its #240 holding.
  • Bridgewater Advisors first reported a position in Novo Nordisk in Q4 2013 and has held it in 11 quarters since.
  • Bridgewater Advisors's Novo Nordisk position peaked at $1.6M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.